よむ、つかう、まなぶ。
03 資料１－１ 帯状疱疹ワクチンファクトシート (67 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_40826.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第26回 6／20）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
３. 引用文献
1.
Arvin AM GD. Varicella-zoster virus. In: Knipe DM HP, ed. Fields Virology: Lippincott Williams & Wilkins; 2013:
2015-57.
2.
Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee
on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57(Rr-5): 1-30; quiz CE2-4.
3.
浅田秀夫. 【ウイルス性皮膚疾患のトピックス】帯状疱疹とワクチン. Derma 2015; (233): 23-8.
4.
浅田秀夫. 【帯状疱疹のトータルケアと合併症対策】帯状疱疹の疫学と免疫学. Derma 2016; (241): 1-6.
5.
Takao Y, Miyazaki Y, Okeda M, et al. Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults
Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study. J Epidemiol 2015;
25(10): 617-25.
6.
Gnann JW, Jr., Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002; 347(5): 340-6.
7.
Oxman MN. Zoster vaccine: current status and future prospects. Clin Infect Dis 2010; 51(2): 197-213.
8.
Cohen JI. Clinical practice: Herpes zoster. N Engl J Med 2013; 369(3): 255-63.
9.
外山望，白木公康. IASR 宮崎県の帯状疱疹の疫学（宮崎スタディ）. NIID IASR, 2013.
10.
国立感染症研究所 感染症疫学センター. 2022 年度 感染症流行予測調査 年齢/年齢群別の水痘抗体保有
状況, 2022 年.
11.
Toyama N, Shiraki K, Miyazaki Dermatologist S. Universal varicella vaccination increased the incidence of herpes
zoster in the child-rearing generation as its short-term effect. J Dermatol Sci 2018; 92(1): 89-96.
12.
Takahashi M, Okada S, Miyagawa H, et al. Enhancement of immunity against VZV by giving live varicella vaccine
to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. Vaccine 2003; 21(25-26): 3845-53.
13.
Asada H. VZV-specific cell-mediated immunity, but not humoral immunity, correlates inversely with the incidence
of herpes zoster and the severity of skin symptoms and zoster-associated pain: The SHEZ study. Vaccine 2019;
37(44): 6776-81.
14.
Okuno Y, Takao Y, Miyazaki Y, et al. Assessment of skin test with varicella-zoster virus antigen for predicting the
risk of herpes zoster. Epidemiol Infect 2013; 141(4): 706-13.
15.
Tang H, Moriishi E, Okamoto S, et al. A community-based survey of varicella-zoster virus-specific immune
responses in the elderly. J Clin Virol 2012; 55(1): 46-50.
16.
Guess HA, Broughton DD, Melton LJ, 3rd, Kurland LT. Epidemiology of herpes zoster in children and adolescents:
a population-based study. Pediatrics 1985; 76(4): 512-7.
17.
Wen SY, Liu WL. Epidemiology of pediatric herpes zoster after varicella infection: a population-based study.
Pediatrics 2015; 135(3): e565-71.
18.
Hope-Simpson RE. THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW
HYPOTHESIS. Proc R Soc Med 1965; 58(1): 9-20.
19.
RJ W. Chickenpox and Herpes Zoster (Varicella-Zoster Virus). In: Bennett JE DR, Blaser MJ, ed. Mandell,
Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed: Saunders; 2015: 1731-7.
20.
Chen SY, Suaya JA, Li Q, et al. Incidence of herpes zoster in patients with altered immune function. Infection 2014;
42(2): 325-34.
21.
Levin MJ. Zoster Vaccines. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM, eds. Plotkin's VACCINES. 7th
66
1.
Arvin AM GD. Varicella-zoster virus. In: Knipe DM HP, ed. Fields Virology: Lippincott Williams & Wilkins; 2013:
2015-57.
2.
Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee
on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57(Rr-5): 1-30; quiz CE2-4.
3.
浅田秀夫. 【ウイルス性皮膚疾患のトピックス】帯状疱疹とワクチン. Derma 2015; (233): 23-8.
4.
浅田秀夫. 【帯状疱疹のトータルケアと合併症対策】帯状疱疹の疫学と免疫学. Derma 2016; (241): 1-6.
5.
Takao Y, Miyazaki Y, Okeda M, et al. Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults
Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study. J Epidemiol 2015;
25(10): 617-25.
6.
Gnann JW, Jr., Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002; 347(5): 340-6.
7.
Oxman MN. Zoster vaccine: current status and future prospects. Clin Infect Dis 2010; 51(2): 197-213.
8.
Cohen JI. Clinical practice: Herpes zoster. N Engl J Med 2013; 369(3): 255-63.
9.
外山望，白木公康. IASR 宮崎県の帯状疱疹の疫学（宮崎スタディ）. NIID IASR, 2013.
10.
国立感染症研究所 感染症疫学センター. 2022 年度 感染症流行予測調査 年齢/年齢群別の水痘抗体保有
状況, 2022 年.
11.
Toyama N, Shiraki K, Miyazaki Dermatologist S. Universal varicella vaccination increased the incidence of herpes
zoster in the child-rearing generation as its short-term effect. J Dermatol Sci 2018; 92(1): 89-96.
12.
Takahashi M, Okada S, Miyagawa H, et al. Enhancement of immunity against VZV by giving live varicella vaccine
to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. Vaccine 2003; 21(25-26): 3845-53.
13.
Asada H. VZV-specific cell-mediated immunity, but not humoral immunity, correlates inversely with the incidence
of herpes zoster and the severity of skin symptoms and zoster-associated pain: The SHEZ study. Vaccine 2019;
37(44): 6776-81.
14.
Okuno Y, Takao Y, Miyazaki Y, et al. Assessment of skin test with varicella-zoster virus antigen for predicting the
risk of herpes zoster. Epidemiol Infect 2013; 141(4): 706-13.
15.
Tang H, Moriishi E, Okamoto S, et al. A community-based survey of varicella-zoster virus-specific immune
responses in the elderly. J Clin Virol 2012; 55(1): 46-50.
16.
Guess HA, Broughton DD, Melton LJ, 3rd, Kurland LT. Epidemiology of herpes zoster in children and adolescents:
a population-based study. Pediatrics 1985; 76(4): 512-7.
17.
Wen SY, Liu WL. Epidemiology of pediatric herpes zoster after varicella infection: a population-based study.
Pediatrics 2015; 135(3): e565-71.
18.
Hope-Simpson RE. THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW
HYPOTHESIS. Proc R Soc Med 1965; 58(1): 9-20.
19.
RJ W. Chickenpox and Herpes Zoster (Varicella-Zoster Virus). In: Bennett JE DR, Blaser MJ, ed. Mandell,
Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed: Saunders; 2015: 1731-7.
20.
Chen SY, Suaya JA, Li Q, et al. Incidence of herpes zoster in patients with altered immune function. Infection 2014;
42(2): 325-34.
21.
Levin MJ. Zoster Vaccines. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM, eds. Plotkin's VACCINES. 7th
66